Matthew J. Giacalone

Direttore operativo presso Vaxiion Therapeutics, Inc.

Consumer Services

Health Technology

Profilo

Dr. Matthew J.
Giacalone is Vice President-Development & Research at Vaxiion Therapeutics, Inc. He received his undergraduate degree from San Diego State University, an MBA from the University of California, San Diego, and a doctorate degree from San Diego State University.

Posizioni attive di Matthew J. Giacalone

Società	Posizione	Inizio
Vaxiion Therapeutics, Inc. Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA.	Direttore operativo	-

Tutte le posizioni attive di Matthew J. Giacalone

Formazione di Matthew J. Giacalone

San Diego State University	Doctorate Degree
University of California San Diego	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew J. Giacalone

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Vaxiion Therapeutics, Inc. Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA.	Health Technology